Q2 2026 Holdings
Filed 2026-08-14 | 31 holdings | $934.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $77.8M | 415,307 | 8.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $65.3M | 489,889 | 7.0% |
| Axsome Therapeutics Inc.(AXSM) | COM | 05464T104 | $53.5M | 218,415 | 5.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $48.4M | 954,360 | 5.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $47.2M | 633,364 | 5.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $47.1M | 1,331,066 | 5.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $46.0M | 84,932 | 4.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $44.9M | 527,412 | 4.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $36.2M | 600,200 | 3.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $34.4M | 329,101 | 3.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $30.7M | 1,670,000 | 3.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $28.1M | 263,851 | 3.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $28.0M | 608,925 | 3.0% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $28.0M | 104,877 | 3.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $28.0M | 83,528 | 3.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $27.9M | 285,771 | 3.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $25.8M | 443,836 | 2.8% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $25.5M | 218,051 | 2.7% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $23.9M | 156,450 | 2.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $23.3M | 602,281 | 2.5% |
| Erasca Inc(ERAS) | COM | 29479A108 | $22.4M | 1,221,721 | 2.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $21.8M | 2,017,284 | 2.3% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $19.7M | 582,497 | 2.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $18.4M | 138,822 | 2.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $17.1M | 154,018 | 1.8% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $15.6M | 164,783 | 1.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $14.9M | 271,227 | 1.6% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $14.8M | 155,343 | 1.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $11.8M | 102,533 | 1.3% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $4.9M | 110,493 | 0.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $3.2M | 26,298 | 0.3% |